VASO-OCCLUSIVE CRISIS
Clinical trials for VASO-OCCLUSIVE CRISIS explained in plain language.
Never miss a new study
Get alerted when new VASO-OCCLUSIVE CRISIS trials appear
Sign up with your email to follow new studies for VASO-OCCLUSIVE CRISIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for sickle cell pain: oral ketamine may reduce opioid need
Symptom relief Recruiting nowThis study explores whether oral ketamine can help control severe pain from sickle-cell crises in adolescents and young adults. Participants receive ketamine every 8 hours for 48 hours alongside standard pain care. The goal is to improve pain relief and reduce reliance on opioids…
Matched conditions: VASO-OCCLUSIVE CRISIS
Phase: PHASE3 • Sponsor: Boston Children's Hospital • Aim: Symptom relief
Last updated May 17, 2026 03:13 UTC
-
Virtual reality offers new hope for sickle cell pain relief
Symptom relief Recruiting nowThis study tests whether using virtual reality (VR) alongside standard pain medicine can better reduce pain in children and young adults with sickle cell disease during a painful crisis. About 76 participants, ages 6 to 25, will either get standard care or standard care plus VR. …
Matched conditions: VASO-OCCLUSIVE CRISIS
Phase: NA • Sponsor: St. Jude Children's Research Hospital • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC